HEADER GLYCOSIDASE 23-MAR-97 2MYR OBSLTE 05-JAN-01 2MYR 1E70 TITLE MYROSINASE, 2-DEOXY-2-FLUORO-GLUCOSYL ENZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYROSINASE; COMPND 3 CHAIN: NULL; COMPND 4 SYNONYM: THIOGLUCOSIDE GLUCOHYDROLASE; COMPND 5 EC: 3.2.3.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SINAPIS ALBA; SOURCE 3 ORGANISM_COMMON: WHITE MUSTARD; SOURCE 4 STRAIN: EMERGO; SOURCE 5 ORGAN: SEED; SOURCE 6 CELL: MYROSIN CELLS; SOURCE 7 CELLULAR_LOCATION: MYROSIN GRAINS KEYWDS FAMILY 1 GLYCOSYL HYDROLASE, GLUCOSINOLATE, MYROSINASE, TIM KEYWDS 2 BARREL, GLYCOSIDASE EXPDTA X-RAY DIFFRACTION AUTHOR W.P.BURMEISTER,S.COTTAZ,H.DRIGUEZ,B.HENRISSAT REVDAT 2 05-JAN-01 2MYR 1 OBSLTE REVDAT 1 16-JUN-97 2MYR 0 JRNL AUTH W.P.BURMEISTER,S.COTTAZ,H.DRIGUEZ,R.IORI, JRNL AUTH 2 S.PALMIERI,B.HENRISSAT JRNL TITL THE CRYSTAL STRUCTURES OF SINAPIS ALBA MYROSINASE JRNL TITL 2 AND A COVALENT GLYCOSYL-ENZYME INTERMEDIATE JRNL TITL 3 PROVIDE INSIGHTS INTO THE SUBSTRATE RECOGNITION JRNL TITL 4 AND ACTIVE-SIDE MACHINERY OF AN S-GLYCOSIDASE JRNL REF STRUCTURE (LONDON) V. 5 663 1997 JRNL REFN ASTM STRUE6 UK ISSN 0969-2126 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.COTTAZ,P.ROLLIN,H.DRIGUEZ REMARK 1 TITL SYNTHESIS OF 2-DEOXY-2-FLUORO-GLUCOTROPAEOLIN, A REMARK 1 TITL 2 THIOGLUCOSIDASE INHIBITOR REMARK 1 REF CARBOHYDR.RES. V. 298 127 1997 REMARK 1 REFN ASTM CRBRAT NE ISSN 0008-6215 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 71.5 REMARK 3 NUMBER OF REFLECTIONS : 71637 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SAME AS NATIVE DATASET REMARK 3 R VALUE (WORKING SET) : 0.140 REMARK 3 FREE R VALUE : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3595 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 55.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6644 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE : 0.2400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 347 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4003 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 350 REMARK 3 SOLVENT ATOMS : 672 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.12 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 4.50 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.14 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.12 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.021 REMARK 3 BOND ANGLES (DEGREES) : 1.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.20 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.020 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.290 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.020 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.290 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM3_MOD.CHO REMARK 3 PARAMETER FILE 3 : PARAM.H2O REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH3.CHO REMARK 3 TOPOLOGY FILE 3 : TOPH.H2O REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MYR COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 6 REMARK 6 ACTIVE SITE NUCLEOPHILE: GLU 409 REMARK 6 AT THE POSITION OF THE GENERAL ACID/BASE: GLN 187 REMARK 7 REMARK 7 WATER MOLECULE WHICH CARRIES OUT POSSIBLY THE NUCLEOPHILIC REMARK 7 ATTACK ON THE GLUCOSYL-ENZYME: HOH 183 REMARK 8 REMARK 8 NO COORDINATES ARE GIVEN FOR RESIDUES 1 - 2. PRO 501 IS REMARK 8 THE LAST VISIBLE RESIDUE. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUN-1996 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : ROTAVATA, AGROVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71637 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 27.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 71.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : 0.04600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.17500 REMARK 200 R SYM FOR SHELL (I) : 0.17500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: MYROSINASE REMARK 200 REMARK 200 REMARK: ISOMORPHOUS TO MYROSINASE BNL-5405 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,1/2+Z REMARK 290 3555 -X,Y,1/2-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 1/2+X,1/2+Y,Z REMARK 290 6555 1/2-X,1/2-Y,1/2+Z REMARK 290 7555 1/2-X,1/2+Y,1/2-Z REMARK 290 8555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.15000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.15000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 67.15000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 68.20000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 67.15000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 68.20000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.15000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 67.15000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 68.20000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.15000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 67.15000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 68.20000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN 1 LIES ON A SPECIAL POSITION. REMARK 375 HOH 380 LIES ON A SPECIAL POSITION. REMARK 375 HOH 556 LIES ON A SPECIAL POSITION. REMARK 375 HOH 613 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP 1 REMARK 465 GLU 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU 409 CD GLU 409 OE2 0.134 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE 136 N - CA - C ANGL. DEV. =-10.8 DEGREES REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 131 DISTANCE = 5.23 ANGSTROMS REMARK 525 HOH 524 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH 568 DISTANCE = 6.09 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 ATOM O1 OF G2F 999 IS NOT PRESENT IN THE ENTRY BECAUSE THE REMARK 600 GROUP FORMS THE GLUCOSYL-ENZYME. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ZNB REMARK 800 SITE_DESCRIPTION: ZN BINDING SITE TOGETHER WITH THE REMARK 800 SYMMETRY-RELATED EQUIVALENTS. REMARK 800 REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 SITE_DESCRIPTION: THE PART OF THE ACTIVE SITE WHICH REMARK 800 RECOGNIZES THE GLUCOSE MOITY OF THE SUBSTRATE. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 THIS ENTRY IS RELATED TO PDB ENTRY 1MYR. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE HAS BEEN DETERMINED FROM THE X-RAY DATA. NO REMARK 999 CORRESPONDING SEQUENCE EXISTS IN A DATABASE. THE TWO REMARK 999 N-TERMINAL RESIDUES HAVE BEEN INFERRED FROM RELATED REMARK 999 SEQUENCES. REMARK 999 REMARK 999 THE SEQUENCE OF 2MYR (DETERMINED FROM THE X-RAY STRUCTURE) REMARK 999 92% IDENTICAL TO A PARTIAL SEQUENCE OF A MYROSINASE FROM REMARK 999 SINAPIS ALBA (SWISS-PROT P29736). THE NUCLEOTIDE SEQUENCE REMARK 999 OF THE GENE ENCODING THE CRYSTALLIZED ENZYME WAS NOT REMARK 999 DETERMINED. SIGNIFICANT DIFFERENCES BEYOND THE REMARK 999 UNCERTAINTY OF A SEQUENCE DETERMINED FROM A CRYSTAL REMARK 999 STRUCTURE SHOW THAT THE ISOENZYME WHICH IS PRESENT IN THE REMARK 999 DEPOSITORS' CRYSTALS IS DIFFERENT FROM THAT WHOSE PARTIAL REMARK 999 SEQUENCE IS KNOWN. THE DEPOSITORS' SEQUENCE IS 70% REMARK 999 IDENTICAL TO THE ONLY KNOWN FULL-LENGTH SEQUENCE OF ANOTHER REMARK 999 MYROSINASE ISOZYME FROM SINAPIS ALBA (SWISS-PROT P29092). REMARK 999 ALL KNOWN MYROSINASE SEQUENCES (FROM SINAPSIS ALBA OR FROM REMARK 999 OTHER CRUCIFERAE) ARE LONGER THAN 2MYR AT THEIR C-TERMINUS REMARK 999 BY APPROXIMATELY 25 RESIDUES. IT IS THEREFORE POSSIBLE REMARK 999 THAT THE SEQUENCE OF 2MYR IS ACTUALLY LONGER THAN THAT SEEN REMARK 999 IN THE X-RAY STRUCTURE. DBREF 2MYR 3 501 PDB 2MYR 2MYR 3 501 SEQRES 1 501 ASP GLU GLU ILE THR CYS GLN GLU ASN ASN PRO PHE THR SEQRES 2 501 CYS GLY ASN THR ASP GLY LEU ASN SER SER SER PHE GLU SEQRES 3 501 ALA ASP PHE ILE PHE GLY VAL ALA SER SER ALA TYR GLN SEQRES 4 501 ILE GLU GLY THR ILE GLY ARG GLY LEU ASN ILE TRP ASP SEQRES 5 501 GLY PHE THR HIS ARG TYR PRO ASP LYS SER GLY PRO ASP SEQRES 6 501 HIS GLY ASN GLY ASP THR THR CYS ASP SER PHE SER TYR SEQRES 7 501 TRP GLN LYS ASP ILE ASP VAL LEU ASP GLU LEU ASN ALA SEQRES 8 501 THR GLY TYR ARG PHE SER ILE ALA TRP SER ARG ILE ILE SEQRES 9 501 PRO ARG GLY LYS ARG SER ARG GLY VAL ASN GLN LYS GLY SEQRES 10 501 ILE ASP TYR TYR HIS GLY LEU ILE ASP GLY LEU ILE LYS SEQRES 11 501 LYS GLY ILE THR PRO PHE VAL THR LEU PHE HIS TRP ASP SEQRES 12 501 LEU PRO GLN THR LEU GLN ASP GLU TYR GLU GLY PHE LEU SEQRES 13 501 ASP PRO GLN ILE ILE ASP ASP PHE LYS ASP TYR ALA ASP SEQRES 14 501 LEU CYS PHE GLU GLU PHE GLY ASP SER VAL LYS TYR TRP SEQRES 15 501 LEU THR ILE ASN GLN LEU TYR SER VAL PRO THR ARG GLY SEQRES 16 501 TYR GLY SER ALA LEU ASP ALA PRO GLY ARG CYS SER PRO SEQRES 17 501 THR VAL ASP PRO SER CYS TYR ALA GLY ASN SER SER THR SEQRES 18 501 GLU PRO TYR ILE VAL ALA HIS HIS GLN LEU LEU ALA HIS SEQRES 19 501 ALA LYS VAL VAL ASP LEU TYR ARG LYS ASN TYR THR HIS SEQRES 20 501 GLN GLY GLY LYS ILE GLY PRO THR MET ILE THR ARG TRP SEQRES 21 501 PHE LEU PRO TYR ASN ASP THR ASP ARG HIS SER ILE ALA SEQRES 22 501 ALA THR GLU ARG MET LYS GLN PHE PHE LEU GLY TRP PHE SEQRES 23 501 MET GLY PRO LEU THR ASN GLY THR TYR PRO GLN ILE MET SEQRES 24 501 ILE ASP THR VAL GLY ALA ARG LEU PRO THR PHE SER PRO SEQRES 25 501 GLU GLU THR ASN LEU VAL LYS GLY SER TYR ASP PHE LEU SEQRES 26 501 GLY LEU ASN TYR TYR PHE THR GLN TYR ALA GLN PRO SER SEQRES 27 501 PRO ASN PRO VAL ASN ALA THR ASN HIS THR ALA MET MET SEQRES 28 501 ASP ALA GLY ALA LYS LEU THR TYR ILE ASN ALA SER GLY SEQRES 29 501 HIS TYR ILE GLY PRO LEU PHE GLU SER ASP GLY GLY ASP SEQRES 30 501 GLY SER SER ASN ILE TYR TYR TYR PRO LYS GLY ILE TYR SEQRES 31 501 SER VAL MET ASP TYR PHE LYS ASN LYS TYR TYR ASN PRO SEQRES 32 501 LEU ILE TYR VAL THR GLU ASN GLY ILE SER THR PRO GLY SEQRES 33 501 SER GLU ASN ARG LYS GLU SER MET LEU ASP TYR THR ARG SEQRES 34 501 ILE ASP TYR LEU CYS SER HIS LEU CYS PHE LEU ASN LYS SEQRES 35 501 VAL ILE LYS GLU LYS ASP VAL ASN VAL LYS GLY TYR LEU SEQRES 36 501 ALA TRP ALA LEU GLY ASP ASN TYR GLU PHE ASN ASN GLY SEQRES 37 501 PHE THR VAL ARG PHE GLY LEU SER TYR ILE ASN TRP ASN SEQRES 38 501 ASN VAL THR ASP ARG ASP LEU LYS LYS SER GLY GLN TRP SEQRES 39 501 TYR GLN LYS PHE ILE SER PRO MODRES ASN 21 ASN GLYCOSYLATION SITE MODRES ASN 90 ASN GLYCOSYLATION SITE MODRES ASN 218 ASN GLYCOSYLATION SITE MODRES ASN 244 ASN GLYCOSYLATION SITE MODRES ASN 265 ASN GLYCOSYLATION SITE MODRES ASN 292 ASN GLYCOSYLATION SITE MODRES ASN 346 ASN GLYCOSYLATION SITE MODRES ASN 361 ASN GLYCOSYLATION SITE MODRES ASN 482 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 21 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 90 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 218 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 244 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 265 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 292 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 346 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 361 ASN GLYCOSYLATION SITE MODRES 2MYR ASN 482 ASN GLYCOSYLATION SITE HET NAG 901 14 HET NAG 911 14 HET NAG 921 14 HET NAG 923 14 HET NAG 931 14 HET NAG 941 14 HET FUC 942 10 HET NAG 943 14 HET MAN 944 11 HET XYS 945 9 HET NAG 951 14 HET FUC 952 10 HET NAG 953 14 HET MAN 954 11 HET XYS 955 9 HET MAN 956 11 HET MAN 957 11 HET NAG 971 14 HET NAG 981 14 HET NAG 983 14 HET NAG 991 14 HET G2F 999 11 HET ZN 1 1 HET SO4 2 5 HET SO4 3 5 HET SO4 4 5 HET SO4 5 5 HET SO4 6 5 HET SO4 7 5 HET SO4 8 5 HET SO4 9 5 HET SO4 10 5 HET SO4 11 5 HET GOL 20 6 HET GOL 21 6 HET GOL 23 6 HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM FUC ALPHA-L-FUCOSE HETNAM MAN ALPHA-D-MANNOSE HETNAM XYS XYLOPYRANOSE HETNAM G2F 2-DEOXY-2FLUORO-GLUCOSE HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN NAG NAG FORMUL 2 NAG 13(C8 H15 N O6) FORMUL 6 FUC 2(C6 H12 O5) FORMUL 6 MAN 4(C6 H12 O6) FORMUL 6 XYS 2(C5 H10 O5) FORMUL 11 G2F C6 H11 F O5 FORMUL 12 ZN ZN 2+ FORMUL 13 SO4 10(O4 S 2-) FORMUL 23 GOL 3(C3 H8 O3) FORMUL 26 HOH *672(H2 O1) HELIX 1 1 SER 22 SER 24 5 3 HELIX 2 2 ALA 37 ILE 40 1 4 HELIX 3 3 ILE 50 ARG 57 1 8 HELIX 4 4 PRO 59 SER 62 1 4 HELIX 5 5 SER 75 LEU 89 1 15 HELIX 6 6 TRP 100 ILE 103 1 4 HELIX 7 7 ARG 109 ARG 111 5 3 HELIX 8 8 GLN 115 LYS 131 1 17 HELIX 9 9 GLN 146 TYR 152 1 7 HELIX 10 10 GLY 154 LEU 156 5 3 HELIX 11 11 PRO 158 PHE 175 5 18 HELIX 12 12 LEU 188 TYR 196 1 9 HELIX 13 13 GLU 222 ASN 244 1 23 HELIX 14 14 THR 246 GLN 248 5 3 HELIX 15 15 ARG 269 PHE 282 1 14 HELIX 16 16 GLY 284 ASN 292 1 9 HELIX 17 17 GLN 297 ARG 306 1 10 HELIX 18 18 PRO 312 VAL 318 1 7 HELIX 19 19 ALA 349 ALA 353 5 5 HELIX 20 20 GLY 378 SER 380 5 3 HELIX 21 21 PRO 386 LYS 399 5 14 HELIX 22 22 ARG 420 MET 424 1 5 HELIX 23 23 TYR 427 LYS 447 1 21 HELIX 24 24 LYS 490 ILE 499 1 10 SHEET 1 A 7 THR 134 THR 138 0 SHEET 2 A 7 GLY 93 SER 97 1 N TYR 94 O THR 134 SHEET 3 A 7 ILE 30 ALA 34 1 N VAL 33 O GLY 93 SHEET 4 A 7 ASN 450 ALA 456 1 N TYR 454 O ILE 30 SHEET 5 A 7 LEU 404 GLU 409 1 N ILE 405 O ASN 450 SHEET 6 A 7 LEU 325 TYR 329 1 N LEU 325 O TYR 406 SHEET 7 A 7 THR 255 THR 258 1 N MET 256 O GLY 326 SHEET 1 B 2 TYR 181 LEU 183 0 SHEET 2 B 2 LYS 251 GLY 253 1 N LYS 251 O TRP 182 SHEET 1 C 3 TRP 260 PRO 263 0 SHEET 2 C 3 THR 332 PRO 337 1 N GLN 333 O TRP 260 SHEET 3 C 3 ALA 355 THR 358 -1 N THR 358 O TYR 334 SSBOND 1 CYS 6 CYS 438 SSBOND 2 CYS 14 CYS 434 SSBOND 3 CYS 206 CYS 214 LINK C1 NAG 901 ND2 ASN 21 LINK C1 NAG 911 ND2 ASN 90 LINK C1 NAG 921 ND2 ASN 218 LINK O4 NAG 921 C1 NAG 923 LINK C1 NAG 931 ND2 ASN 244 LINK C1 NAG 941 ND2 ASN 265 LINK O3 NAG 941 C1 FUC 942 LINK O4 NAG 941 C1 NAG 943 LINK O4 NAG 943 C1 MAN 944 LINK O2 MAN 944 C1 XYS 945 LINK C1 NAG 951 ND2 ASN 292 LINK O3 NAG 951 C1 FUC 952 LINK O4 NAG 951 C1 NAG 953 LINK O4 NAG 953 C1 MAN 954 LINK O2 MAN 954 C1 XYS 955 LINK O3 MAN 954 C1 MAN 956 LINK O6 MAN 954 C1 MAN 957 LINK C1 NAG 971 ND2 ASN 346 LINK C1 NAG 981 ND2 ASN 361 LINK O4 NAG 981 C1 NAG 983 LINK C1 NAG 991 ND2 ASN 482 LINK ZN ZN 1 NE2 HIS 56 LINK ZN ZN 1 OD2 ASP 70 LINK C1 G2F 999 OE2 GLU 409 LINK ZN ZN 1 NE2 HIS 56 3656 LINK ZN ZN 1 OD2 ASP 70 3656 LINK NE2 HIS 56 ZN ZN 1 3656 LINK OD2 ASP 70 ZN ZN 1 3656 LINK ZN ZN 1 ZN ZN 1 3656 CISPEP 1 ASN 10 PRO 11 0 -2.99 CISPEP 2 ALA 202 PRO 203 0 6.52 CISPEP 3 TRP 457 ALA 458 0 0.13 SITE 1 ZNB 2 HIS 56 ASP 70 SITE 1 ACT 10 GLN 39 HIS 141 ASN 186 GLN 187 SITE 2 ACT 10 TYR 330 GLU 409 TRP 457 GLU 464 SITE 3 ACT 10 PHE 465 PHE 473 CRYST1 134.300 136.400 80.300 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007446 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012453 0.00000